Florida Cancer Specialists & Research Institute (FCS) physicians and senior leaders are the co-authors of 32 research studies that will be presented at the American Society of Clinical Oncology (ASCO®) 2021 Annual Meeting being held June 4 – 8, 2021.
Medical oncologist Syed Zafar MD, who practices at three Florida Cancer Specialists & Research Institute (FCS) locations in Lee County, is co-author of a new study entitled “Adjuvant Nivolumab in Resected Esophageal or Gastroesophageal Junction Cancer.”
Julio Lautersztain, MD, medical oncologist who practices at Florida Cancer Specialists & Research Institute (FCS) locations in Tampa and Brandon, is co-author of a new study entitled “Novel mechanism of hereditary pyropoikilocytosis phenotype due to co‐inheritance of β globin and α spectrin mutations.”
Pareshkumar Patel, MD, medical oncologist with Florida Cancer Specialists & Research Institute (FCS), is the recipient of the 2021 FLASCO Advocate of the Year Award.
Physicians and leaders of Florida Cancer Specialists & Research Institute (FCS) are participating in the Florida Society of Clinical Oncology (FLASCO) 2021 Business of Oncology Summit & Spring Session being held in Kissimmee, FL on April 16 & 17.
Physicians, clinicians and administrative leaders of Florida Cancer Specialists & Research Institute (FCS) will be participating in the virtual 2021 Community Oncology Conference hosted by the Community Oncology Alliance (COA) on April 8 & 9, 2021.
The donation of a blanket warmer machine will provide added comfort to patients who receive care at Florida Cancer Specialists & Research Institute’s (FCS) Lecanto location.
Florida Cancer Specialists & Research Institute Studies Featured at ASCO® 2021 Annual MeetingFlorida Cancer Specialists & Research Institute (FCS) physicians and senior leaders are the co-authors of 32 research studies that will be presented at the American Society of Clinical Oncology (ASCO®) 2021 Annual Meeting being held June 4 – 8, 2021.
Syed Zafar, MD Co-Authors Study on Adjuvant Nivolumab in Esophageal/Gastroesophageal Junction CancerMedical oncologist Syed Zafar MD, who practices at three Florida Cancer Specialists & Research Institute (FCS) locations in Lee County, is co-author of a new study entitled “Adjuvant Nivolumab in Resected Esophageal or Gastroesophageal Junction Cancer.”
Julio Lautersztain, MD Co-Authors Study on Novel Co-Inheritance of Beta Globin and Spectrin MutationsJulio Lautersztain, MD, medical oncologist who practices at Florida Cancer Specialists & Research Institute (FCS) locations in Tampa and Brandon, is co-author of a new study entitled “Novel mechanism of hereditary pyropoikilocytosis phenotype due to co‐inheritance of β globin and α spectrin mutations.”
Florida Cancer Specialists & Research Institute Medical Oncologist Paresh Patel, MD Named 2021 FLASCO “Advocate of the Year”Pareshkumar Patel, MD, medical oncologist with Florida Cancer Specialists & Research Institute (FCS), is the recipient of the 2021 FLASCO Advocate of the Year Award.
Florida Cancer Specialists & Research Institute Physicians Featured Speakers at Community Oncology Alliance Spring SessionPhysicians, clinicians and administrative leaders of Florida Cancer Specialists & Research Institute (FCS) will be participating in the virtual 2021 Community Oncology Conference hosted by the Community Oncology Alliance (COA) on April 8 & 9, 2021.
Florida Cancer Specialists Lecanto Office Receives Blanket Warmer DonationThe donation of a blanket warmer machine will provide added comfort to patients who receive care at Florida Cancer Specialists & Research Institute’s (FCS) Lecanto location.
Florida Cancer Specialists & Research Institute Appoints Gustavo Fonseca, MD, FACP as Medical Director of Clinical Research ProgramFlorida Cancer Specialists & Research Institute (FCS) has named Gustavo “Gus” Fonseca, MD, FACP as Medical Director of the Clinical Research Program.